<?xml version="1.0" encoding="UTF-8"?>
<ref id="B8">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Anonye</surname>
    <given-names>B. O.</given-names>
   </name>
   <name>
    <surname>Nweke</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Furner-Pardoe</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Gabrilska</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Rafiq</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ukachukwu</surname>
    <given-names>F.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2020</year>). 
  <article-title>The safety profile of Baldâ€™s eyesalve for the treatment of bacterial infections</article-title>. 
  <source>bioRxiv</source>. 
  <ext-link ext-link-type="uri" xlink:href="https://www.nature.com/articles/s41598-020-74242-2" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.nature.com/articles/s41598-020-74242-2</ext-link>
  <pub-id pub-id-type="doi">10.1101/2020.04.23.041749</pub-id>.
 </mixed-citation>
</ref>
